HilleVax Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	218.31	281.03	124.57	0.46
Short-Term Investments	86.81	0	0	0
Cash & Cash Equivalents	305.11	281.03	124.57	0.46
Cash Growth	8.57%	125.61%	27157.33%	-
Other Current Assets	5.56	9.58	0.14	0.05
Total Current Assets	310.68	290.61	124.71	0.51
Property, Plant & Equipment	32.1	24.95	0.23	0
Other Long-Term Assets	1.66	1.65	2.22	0
Total Long-Term Assets	33.76	26.6	2.45	0
Total Assets	344.43	317.21	127.16	0.51
Accounts Payable	7.46	4.74	1.02	0.13
Current Debt	3.12	0.04	158.31	3.02
Other Current Liabilities	18.69	8.27	68.43	0.12
Total Current Liabilities	29.27	13.05	227.76	3.28
Long-Term Debt	48.08	36.36	0.15	0
Other Long-Term Liabilities	1.57	0.58	0	0
Total Long-Term Liabilities	49.64	36.94	0.15	0
Total Liabilities	78.91	49.98	227.92	3.28
Total Debt	51.19	36.4	158.46	3.02
Debt Growth	40.65%	-77.03%	5140.11%	-
Retained Earnings	-388.56	-264.99	-105.18	-2.78
Comprehensive Income	-0.91	-0.28	0	0
Shareholders' Equity	265.53	267.23	-100.76	-2.77
Net Cash / Debt	253.92	244.63	-33.9	-2.57
Net Cash / Debt Growth	3.80%	-	-	-
Net Cash Per Share	6.25	9.01	-6.03	-0.59
Working Capital	281.41	277.57	-103.06	-2.77
Book Value Per Share	6.54	9.84	-17.93	-0.64

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).